Bioventus Inc. financial data

Symbol
BVS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4721 Emperor Boulevard, Suite 100, Durham, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 % +28.1%
Quick Ratio 50.4 % +40.9%
Debt-to-equity 350 % +12.6%
Return On Equity -19.7 % +76.8%
Return On Assets -5.23 % +79.2%
Operating Margin -3.81 % +91.5%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 75.4M USD -63.3%
Weighted Average Number of Shares Outstanding, Basic 64.1M shares +2.41%
Weighted Average Number of Shares Outstanding, Diluted 64.1M shares +2.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 537M USD +5.14%
Research and Development Expense 12.9M USD -27.5%
Operating Income (Loss) -20.5M USD +91%
Nonoperating Income (Expense) -40.7M USD -2.36%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -61.1M USD +77.2%
Income Tax Expense (Benefit) -6.58M USD +83.6%
Net Income (Loss) Attributable to Parent -42M USD +85.2%
Earnings Per Share, Basic -0.63 USD/shares +86.3%
Earnings Per Share, Diluted -0.63 USD/shares +86.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32M USD +8.86%
Accounts Receivable, after Allowance for Credit Loss, Current 137M USD +14.8%
Inventory, Net 87.6M USD -9.01%
Assets, Current 309M USD +18.5%
Deferred Income Tax Assets, Net 6.88M USD
Property, Plant and Equipment, Net 27.6M USD +20.3%
Operating Lease, Right-of-Use Asset 10.4M USD -32%
Intangible Assets, Net (Excluding Goodwill) 425M USD -16%
Goodwill 7.46M USD 0%
Assets 792M USD -5.35%
Accounts Payable, Current 24.4M USD -40.9%
Accrued Liabilities, Current 140M USD +15%
Contract with Customer, Liability, Current 2.35M USD -18.9%
Liabilities, Current 231M USD +29.2%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 8.47M USD -32.2%
Other Liabilities, Noncurrent 26.9M USD -15.8%
Liabilities 603M USD -0.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax -17K USD -103%
Retained Earnings (Accumulated Deficit) -350M USD -13.6%
Stockholders' Equity Attributable to Parent 151M USD -17.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 189M USD -19%
Liabilities and Equity 792M USD -5.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.01M USD -341%
Net Cash Provided by (Used in) Financing Activities -4.24M USD -115%
Net Cash Provided by (Used in) Investing Activities -1M USD +93.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.8M USD -177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32M USD +8.86%
Deferred Tax Assets, Valuation Allowance 46M USD +1714%
Deferred Tax Assets, Gross 46.8M USD +58.6%
Operating Lease, Liability 11.5M USD -30%
Payments to Acquire Property, Plant, and Equipment 291K USD -91.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42.6M USD +84.9%
Lessee, Operating Lease, Liability, to be Paid 16M USD -22.5%
Property, Plant and Equipment, Gross 58.5M USD +27%
Operating Lease, Liability, Current 3.04M USD -23.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.08M USD -12.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.57M USD +1.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.37M USD -35.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.25M USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 10.8M USD -41.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.73M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.62M USD -19.4%
Operating Lease, Payments 1.18M USD +7.09%
Additional Paid in Capital 501M USD +2.11%
Depreciation, Depletion and Amortization 11.8M USD -28.5%
Deferred Tax Assets, Net of Valuation Allowance 840K USD -96.9%
Share-based Payment Arrangement, Expense 3.46M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%